Differential effects of oral vs transdermal ERT on CRP in postmenopausal – (04-23-03)



Differential effects of oral vs transdermal ERT on CRP in postmenopausal

Hate to rely all my sad stories, but I had a woman in this week; 60 years old, multiple open heart surgeries, stent placement in both renal arteries and 3 strokes. You would think her cardiologists (a long stream of them) would at some point have discussed insulin management, homocysteine and CRP with her. Appearantly not. She is also currently on oral ERT which, as we see in this study raises CRP levels.

Cardiosource

James Bogash

For more than a decade, Dr. Bogash has stayed current with the medical literature as it relates to physiology, disease prevention and disease management. He uses his knowledge to educate patients, the community and cyberspace on the best way to avoid and / or manage chronic diseases using lifestyle and targeted supplementation.







Email: